ComplyRx

Targeted & bispecific oncology · Live ClinicalTrials.gov data

Teclistamab (Tecvayli) clinical trial pipeline

The timeline below tracks the 16 largest phase 2–4 teclistamab (Tecvayli) trials on ClinicalTrials.gov by enrolment, 8 of them actively recruiting. The next phase 3 primary completion among them is expected Dec 2027. Refreshed daily. Add up to four competitors to compare pipelines side by side.

16+

Major trials tracked

11

Phase 3 trials

8

Actively recruiting

Dec 2027

Next phase 3 primary completion

9,711

Participants across trials

Janssen Research & Development, LLC

Lead sponsor by trial count

teclistamab (16)16 active2020–2038
teclistamab
Key
Actual date
Anticipated
Forecast to primary completion
RecruitingActive, not recruitingNot yet recruiting
'20
'22
'24
'26
'28
'30
'32
'34
'36
'38
teclistamab
MajesTEC-1P2
MajesTEC-4P3
MajesTEC-7P3
HD10/DSMMXXP2
MajesTEC-9P3
MASTER-2P2
MonumenTAL-6P3
MMRC Horizon One: RRMM (MMRC-099)P2
A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple MyelomaP3
TRIlogy-4P3
TRIlogy-5P3
AugMMentP3
iFITP3
TiTanP3
A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple MyelomaP3
BLOOD-doseP4

Upcoming readouts

13 ahead · teclistamab

Select a trial to load its full ClinicalTrials.gov record.

Key teclistamab trials

Top 12 of the 16 tracked phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.

TrialTitlePhaseStatusPrimary completion
NCT07474961BLOOD-dose: BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases.Phase 4Not yet recruitingDec 2036
NCT07138209A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dex…Phase 3RecruitingDec 2027
NCT05243797MajesTEC-4: Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenal…Phase 3RecruitingApr 2028
NCT07258511TRIlogy-4: A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antib…Phase 3RecruitingDec 2028
NCT07518186TRIlogy-5: A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multi…Phase 3RecruitingApr 2029
NCT05552222MajesTEC-7: A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab…Phase 3RecruitingApr 2031
NCT07649525iFIT: Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Thei…Phase 3RecruitingJun 2033
NCT05572515MajesTEC-9: A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) o…Phase 3Active, not recruitingOct 2025
NCT06208150MonumenTAL-6: A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, P…Phase 3Active, not recruitingApr 2026
NCT07671287AugMMent: GMMG-HD11/DSMM XXI/64007957MMY3010Phase 3Not yet recruitingFeb 2031
NCT07740486TiTan: A Study Comparing Treatment With Teclistamab and Talquetamab Versus Daratumumab and Lenalidomide…Phase 3Not yet recruitingJun 2031
NCT07728188A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus O…Phase 3Not yet recruitingFeb 2033

Track teclistamab with ComplyRx

Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.

Track teclistamab

Related drug pipelines

Compare teclistamab vs amivantamabCompare teclistamab vs tarlatamab

FAQ

How many clinical trials are running for teclistamab?
ClinicalTrials.gov lists more than 16 phase 2–4 teclistamab trials. This page tracks the 16 largest by enrolment: 4 phase 2, 11 phase 3, and 1 phase 4 among them, with 8 actively recruiting. Updated daily.
Are there clinical trials for Tecvayli?
Tecvayli is the brand name for teclistamab, so teclistamab trials on ClinicalTrials.gov cover it. ClinicalTrials.gov lists more than 16 phase 2–4 teclistamab trials. This page tracks the 16 largest by enrolment: 4 phase 2, 11 phase 3, and 1 phase 4 among them, with 8 actively recruiting. Updated daily.
Where does this data come from?
All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
Can I compare teclistamab against other drugs?
Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
Join the waitlist

Be the first to access ComplyRx

We'll let you know as soon as your spot opens to use ComplyRx.

By joining, you agree to our Privacy Policy.